NCT03916497View on ClinicalTrials.gov

Anti-CMV Cellular Immunity Quantification Using an IGRA Test in Kidney Transplant récipients and Hemodialysis Patients, Comparison to Control Patients

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

April 30, 2019

Primary Completion Date

July 30, 2019

Study Completion Date

July 30, 2019

Conditions
Quantiferon-CMVCytomegalovirus InfectionsKidney Transplant InfectionHemodialysis
Interventions
DIAGNOSTIC_TEST

Quantiferon CMV

Evaluate and compare interferon gamma (IFNy) production by T CD8 cells exposed to CMV antigens in CMV seropositive kidney transplant recipients, hemodialysis and control patients

Trial Locations (1)

38043

Chu Grenoble Alpes, Grenoble

All Listed Sponsors
lead

University Hospital, Grenoble

OTHER

NCT03916497 - Anti-CMV Cellular Immunity Quantification Using an IGRA Test in Kidney Transplant récipients and Hemodialysis Patients, Comparison to Control Patients | Biotech Hunter | Biotech Hunter